相关实验视频

Updated: May 5, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

以ATP为燃料的协调纳米激剂的STING激活,以提高抗瘤免疫力

Si-Yao Han¹, Sui-Juan Zheng¹, Jia-Qi Luo¹

¹School of Medicine, South China University of Technology, Guangzhou, 510006, China.

Bioactive materials

|February 20, 2026

概括

研究人员开发了ATP-Mn协调纳米粒子 (CNPs),以增强干扰素基因 (cGAS-STING) 循环GMP-AMP合成酶刺激器通路,用于癌症免疫治疗. 这种新的纳米粒子策略有效地提高了抗瘤免疫力,并抑制了瘤的生长.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
生物化学生物化学

背景情况:

干扰素基因 (cGAS-STING) 的循环GMP-AMP合成酶刺激通路对于先天免疫反应至关重要.
离子 (Mn2+) 调节cGAS-STING通路,但具有快速清除和毒性等局限性.
腺三酸盐 (ATP) 具有与生物功能相关的独特化学特性.

研究的目的:

开发一种用于增强cGAS-STING激活和抗瘤免疫力的新型纳米粒子系统.
为了克服与自由离子应用相关的局限性.
探索ATP作为结构成分和免疫刺激剂.

主要方法:

通过协调ATP与Mn2+并涂上脂质来合成ATP-Mn协调纳米粒子 (CNPs).
在体外评估了ATP-Mn CNPs对cGAS-STING通路激活的影响.
在小鼠模型中评估了ATP-Mn CNPs的in vivo抗瘤有效性和免疫调节.
研究了ATP-Mn CNPs与免疫检查点抑制剂的联合治疗.

主要成果:

ATP-Mn CNPs已成功合成为稳定的纳米粒子.
ATP-Mn CNPs显著提高了cGAS-STING通路基因的调节,并激活了信号传递.
用ATP-Mn CNPs的治疗促进了M1巨细胞的两极分化,抑制了瘤的生长.
ATP-Mn CNPs增强了细胞毒性淋巴细胞透和改善了生存率,特别是当与免疫检查点抑制剂相结合时.

结论:

ATP-Mn CNPs代表了推动cGAS-STING激活和增强抗瘤免疫力的有希望的策略.
这种方法有效地利用ATP作为连接体和免疫刺激剂.
开发的纳米粒子克服了自由Mn2+的局限性,为癌症免疫治疗提供了新的途径.

关键词:

亚丁酸三酸盐是一种氨酸三酸盐.癌症金属免疫疗法癌症免疫疗法协调纳米颗粒是什么意思离子是一种离子.cGAS-STING的激活方式

更多相关视频

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.